Steven Cohen Sutro Biopharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,997,453 shares of STRO stock, worth $8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,997,453
Previous 4,447,634
32.61%
Holding current value
$8 Million
Previous $13 Million
20.41%
% of portfolio
0.03%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding STRO
# of Institutions
136Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$19.2 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$11.2 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$7.56 Million1.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.25MShares$6.01 Million0.01% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $139M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...